Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
17.4M
-
Shares change
-
-1.34M
-
Total reported value, excl. options
-
$146M
-
Value change
-
-$9.99M
-
Put/Call ratio
-
0.57
-
Number of buys
-
43
-
Number of sells
-
-36
-
Price
-
$8.37
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q4 2016
95 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q4 2016.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.4M shares
of 177M outstanding shares and own 9.83% of the company stock.
Largest 10 shareholders include JENNISON ASSOCIATES LLC (3.22M shares), FMR LLC (2.62M shares), Versant Venture Management, LLC (2.22M shares), SV Life Sciences Advisers, LLC (1.61M shares), WELLINGTON MANAGEMENT GROUP LLP (971K shares), Polaris Venture Management Co. V, L.L.C. (789K shares), VANGUARD GROUP INC (728K shares), BlackRock Fund Advisors (575K shares), BlackRock Institutional Trust Company, N.A. (537K shares), and COLUMBUS CIRCLE INVESTORS (470K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.